This hypothesis is in accordance with initial studies reporting a negative association between survival and the presence of hypermethylated ER-α, RASSF1A, RAR-β2, or MINT31 DNA in neoplastic tissues or sera of stage III/IV CM patients [22-24]. The gene discussed is ESR1; the disease is cutaneous mastocytosis.